Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors

Published:2016-01-14 Issue:5 Volume:57 Page:708-714
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Deppen Stephen A.,Liu Eric,Blume Jeffrey D.,Clanton Jeffrey,Shi Chanjuan,Jones-Jackson Laurie B.,Lakhani Vipul,Baum Richard P.,Berlin Jordan,Smith Gary T.,Graham Michael,Sandler Martin P.,Delbeke Dominique,Walker Ronald C.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference33 articles.

1. Gastroenteropancreatic neuroendocrine tumours

2. A 5-decade analysis of 13,715 carcinoid tumors

3. Use of somatostatin analog in management of carcinoid syndrome

4. Oberndorfer S , ed. Karzinoide Handbuch der Speziellen. Berlin, Germany: Verlag von Julius Springer; 1928.

5. Surgical Treatment of Advanced-Stage Carcinoid Tumors

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga‐DOTATATE PET/CT: How is it reliable in imaging of cases having clinical suspicion of insulinomas?;European Journal of Radiology;2024-10

2. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine;Chemical & Biomedical Imaging;2024-08-22

4. Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors;Annals of Surgical Oncology;2024-06-22

5. Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging;World Journal of Nuclear Medicine;2024-05-07